Literature DB >> 16942007

'Concealing the evidence': the importance of appearance concerns for patients with systemic lupus erythematosus.

E D Hale1, G J Treharne, Y Norton, A C Lyons, K M J Douglas, N Erb, G D Kitas.   

Abstract

Outwardly visible signs associated with systemic lupus erythematosus (SLE) can include facial rashes, alopecia and weight gain. We sought to understand the concerns of SLE patients about their appearance and the recognition of this by healthcare professionals. Semi-structured interviews were carried out with 10 women aged 26-68 years diagnosed with SLE for one to 12 years. Data were analysed with Interpretative Phenomenological Analysis (IPA); this seeks to describe and provide understanding of people's experience of a phenomenon by studying in-depth a small number from a relatively homogeneous group (women with SLE in the present study). Analysis revealed three themes concerning appearance issues. Participants described public self-consciousness after the onset of SLE. Cosmetics and clothing were used skilfully to appear 'normal', hide the 'self' and assert control but could increase feelings of difference and isolation. Self-imposed isolation was also described and may relate to depression. The understanding of family, friends, colleagues and healthcare providers was also important. Awareness of the psychosocial concerns of SLE patients with life-changing skin disease may enable multidisciplinary healthcare teams to offer a more sensitive, practical service. The physical and emotional needs of SLE patients need to be ascertained and appropriate educational and psychological services are required.

Entities:  

Mesh:

Year:  2006        PMID: 16942007     DOI: 10.1191/0961203306lu2310xx

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

Review 1.  Qualitative Methods to Advance Care, Diagnosis, and Therapy in Rheumatic Diseases.

Authors:  Lesley Ann Saketkoo; John D Pauling
Journal:  Rheum Dis Clin North Am       Date:  2018-02-21       Impact factor: 2.670

2.  Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Luis A González; Jie Zhang; Luis M Vilá; John D Reveille; Gerald McGwin
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

3.  Life course changes provoked by chronic disease: A study on everyday life for patients with systemic lupus erythematosus.

Authors:  Zheng Huangfu
Journal:  Int J Nurs Sci       Date:  2020-05-29

4.  Unmet needs of patients with systemic lupus erythematosus.

Authors:  Sharon Danoff-Burg; Fred Friedberg
Journal:  Behav Med       Date:  2009       Impact factor: 3.104

5.  How do patients with systemic autoimmune rheumatic disease perceive the use of their medications: a systematic review and thematic synthesis of qualitative research.

Authors:  Hans Haag; Tim Liang; J Antonio Avina-Zubieta; Mary A De Vera
Journal:  BMC Rheumatol       Date:  2018-04-02

6.  'More extraordinary than mundane … ' A phenomenological analysis of the experiences of individuals living with CLE and their taking care in the sun.

Authors:  Bláithín McGarry; Donal O'Kane; Collette McCourt; Gerard J Gormley
Journal:  Lupus       Date:  2020-09-17       Impact factor: 2.911

7.  Prevalence and biopsychosocial factors associated with depressive symptoms among patients living with systemic lupus erythematosus in clinical settings in urban Thailand.

Authors:  Nirunya Narupan; Acharaporn Seeherunwong; Walailak Pumpuang
Journal:  BMC Psychiatry       Date:  2022-02-09       Impact factor: 3.630

8.  Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study.

Authors:  Yoshia Miyawaki; Sayaka Shimizu; Yusuke Ogawa; Ken-Ei Sada; Yu Katayama; Yosuke Asano; Keigo Hayashi; Yuriko Yamamura; Sumie Hiramatsu-Asano; Keiji Ohashi; Michiko Morishita; Haruki Watanabe; Mariko Takano-Narazaki; Yoshinori Matsumoto; Nobuyuki Yajima; Ryusuke Yoshimi; Yasuhiro Shimojima; Shigeru Ohno; Hiroshi Kajiyama; Kunihiro Ichinose; Shuzo Sato; Michio Fujiwara; Hajime Yamazaki; Yosuke Yamamoto; Jun Wada; Shunichi Fukuhara
Journal:  Arthritis Res Ther       Date:  2021-03-10       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.